How to treat Urticaria?

Báwo ni wọ́n ṣe lè wo àrùn urticaria sàn?

Orticaria, tí wọ́n sábà máa ń pè ní hives, jẹ́ àìsàn awọ ara tó máa ń mú kí ara máa gbóná, tó sì lè fara hàn níbikíbi tó bá wà nínú ara.

Ọ̀pọ̀ nǹkan ló lè fa rẹ̀, títí kan àìsàn kan, àrùn tó ń ṣe èèyàn, tàbí àìsàn kan tó ń ṣe èèyàn.

Ìtọjú àrùn urticaria sinmi lórí bí àìsàn náà ṣe le tó àti ohun tó fà á.

Àwọn ìtọ́jú tí wọ́n sábà máa ń lò rèé:

1. Àwọn oògùn tí wọ́n ń pè ní antihistamines: Àwọn oògùn wọ̀nyí máa ń dín ìbàjẹ́ àti ìbàjẹ́ kù nípa dídènà ipa histamine, tó jẹ́ kẹ́míkà tí ara máa ń tú jáde nígbà tí àrùn bá ń ṣe é.

Àwọn oògùn antihistamines tí wọ́n ń tà láìsí ìtọ́jú bíi diphenhydramine (Benadryl) tàbí loratadine (Claritin) lè wúlò nínú àwọn ọ̀ràn tí kò fi bẹ́ẹ̀ le.

Nígbà tí àrùn náà bá le gan-an, dókítà lè fúnni ní oògùn antihistamine tó lágbára ju ti tẹ́lẹ̀ lọ.

2. Corticosteroids: Nínú àwọn ọ̀ràn tí àwọn oògùn antihistamines kò bá ṣiṣẹ́, a lè fúnni ní corticosteroids bíi prednisone láti dín àìsàn kù kí wọ́n sì dín ètò ààbò kù.

Wọ́n sábà máa ń mu àwọn oògùn wọ̀nyí ní ẹnu, wọ́n sì lè mú kí ara tù wọ́n kíákíá.

3. Àwọn oògùn tó ń dènà ààbò: Nígbà tí àrùn urticaria bá ń báni fínra tí kò sì lè dáhùn sí ìtọ́jú mìíràn, a lè fúnni ní àwọn oògùn tó ń dènà ààbò bí cyclosporine tàbí methotrexate láti dènà ètò ààbò àti láti dín ìdààmú kù.

4. Omalizumab: Oògùn yìí jẹ́ àjẹsára monoclonal tí a lè fi ọgbẹ́ ṣe tí ó máa ń dí immunoglobulin E (IgE) lọ́wọ́, èyí tó jẹ́ èròjà protein tí ó máa ń fa àìsàn.

Wọ́n sábà máa ń lò ó fún àrùn urticaria tí kì í dáhùn sí àwọn ìtọ́jú mìíràn.

5. Yẹra fún àwọn ohun tó ń fa àrùn urticaria: Fífi àwọn ohun tó ń fa àrùn urticaria hàn, kí o sì yẹra fún wọn lè ràn ẹ́ lọ́wọ́ láti dènà àrùn náà.

Lára àwọn ohun tó sábà máa ń fa àrùn náà ni àwọn oúnjẹ kan, àwọn oògùn kan, àwọn kòkòrò kan tó máa ń gún èèyàn, ooru, òtútù, tàbí oòrùn.

6. Àwòrán tí ó tutù: Fífi àwòrán tí ó tutù sórí ibi tí àrùn náà ti ń ṣe lè dín ìbànújẹ́ àti ìbànújẹ́ kù.

7. Àwọn aṣọ tí wọ́n fi omi bo: Wọ́n lè lo àwọn aṣọ tí wọ́n fi omi bo láti mú kí ìrora kúrò, kí wọ́n sì dín àìsàn náà kù.

Wọ́n máa ń fi aṣọ rírẹ̀ yí ibi tó ní àrùn náà ká, wọ́n á sì wá fi aṣọ gbígbẹ bò ó láti mú kí omi máa wà níbẹ̀.

8. Ìtọ́jú Ìmọ́lẹ̀: Ìmọ́lẹ̀ ultraviolet lè ràn wá lọ́wọ́ láti dín ètò ààbò kù, ó sì lè dín ìdààmú ara kù nínú àwọn àìsàn kan tó ń fa àrùn urticaria.

Ó ṣe pàtàkì láti lọ bá oníṣègùn kan fún àyẹ̀wò àti ìtọ́jú tó tọ́ fún àrùn urticaria.

Wọ́n lè ràn wá lọ́wọ́ láti mọ ohun tó ń fa àrùn náà, kí wọ́n sì fún wa ní ìtọ́jú tó yẹ jù lọ.

Àwọn ìtumọ̀

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Deleanu D, Nedelea I, Petricau C, Leru P, Dumitrascu D, Muntean A: Clinical impact of omalizumab in refractory chronic urticaria: One centre experience. Exp Ther Med. 2019, 18 (6): 5078-5081.

Grundmann SA, Kiefer S, Luger TA, Brehler R: Delayed pressure urticaria - dapsone heading for first-line therapy? J Dtsch Dermatol Ges. 2011, 9 (11): 908-12.

Staumont-Sallé D, Piette F, Delaporte E: [Etiological diagnosis and treatment of chronic urticaria]. Rev Med Interne. 2003, 24 (1): 34-44.

Akashi R, Ishiguro N, Shimizu S, Kawashima M: Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol. 2011, 38 (8): 761-6.

Calogiuri G, Nettis E, Mandurino-Mirizzi A, Di Leo E, Macchia L, Foti C, Vacca A, Kounis NG: Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report. Antiinflamm Antiallergy Agents Med Chem. 2020, 19 (3): 335-339.

Ìyàsímímọ́: ìtọ́jú ìlera

Oju opo wẹẹbu yii ni a pese fun eto-ẹkọ ati awọn idi alaye nikan ati pe ko ṣe agbekalẹ pese imọran iṣoogun tabi awọn iṣẹ ọjọgbọn.

A ò gbọ́dọ̀ lo ìsọfúnni tó wà nínú ìwé náà láti ṣe àyẹ̀wò tàbí láti wo àìsàn tàbí àìsàn kan wò, àwọn tó bá sì ń wá ìmọ̀ràn nípa ìṣègùn fúnra wọn gbọ́dọ̀ bá dókítà tó ní ìwé àṣẹ sọ̀rọ̀.

Jọwọ ṣe akiyesi nẹtiwọọki neural ti o ṣe agbejade awọn idahun si awọn ibeere, jẹ pataki ti ko tọ nigbati o ba de si akoonu nọmba. Fun apẹẹrẹ, nọmba awọn eniyan ti a ṣe ayẹwo pẹlu aisan kan pato.

Nigbagbogbo wa imọran ti dokita rẹ tabi olupese ilera ti o ni oye miiran nipa ipo iṣoogun kan. Maṣe gbagbe imọran iṣoogun ọjọgbọn tabi idaduro ni wiwa rẹ nitori nkan ti o ti ka lori oju opo wẹẹbu yii. Ti o ba ro pe o le ni pajawiri iṣoogun, pe 911 tabi lọ si yara pajawiri ti o sunmọ julọ lẹsẹkẹsẹ. Ko si ibatan dokita-aisan ti a ṣẹda nipasẹ oju opo wẹẹbu yii tabi lilo rẹ. Bẹni BioMedLib tabi awọn oṣiṣẹ rẹ, tabi ẹnikẹni ti o ṣe alabapin si oju opo wẹẹbu yii, ṣe eyikeyi awọn aṣoju, ṣalaye tabi tumọ, pẹlu ọwọ si alaye ti a pese nibi tabi lilo rẹ.

Ìyàsímímọ́: ẹ̀tọ́ ọmọnìyàn

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) n pese atunṣe fun awọn onihun aṣẹ-aṣẹ ti o gbagbọ pe ohun elo ti o han lori Intanẹẹti ṣe ilokulo awọn ẹtọ wọn labẹ ofin aṣẹ-aṣẹ AMẸRIKA.

Ti o ba gbagbọ ni igbagbọ to dara pe eyikeyi akoonu tabi ohun elo ti o wa ni asopọ pẹlu oju opo wẹẹbu wa tabi awọn iṣẹ ṣe ilokulo aṣẹ-aṣẹ rẹ, iwọ (tabi aṣoju rẹ) le firanṣẹ akiyesi kan si wa ti o beere pe a yọ akoonu tabi ohun elo naa kuro, tabi idilọwọ iraye si rẹ.

A gbọdọ firanṣẹ awọn iwifunni ni kikọ nipasẹ imeeli (wo abala "Ibaṣepọ" fun adirẹsi imeeli).

DMCA nilo pe akiyesi rẹ ti ilokulo aṣẹ-aṣẹ ti a fi ẹsun kan pẹlu alaye wọnyi: (1) apejuwe ti iṣẹ ti o ni aṣẹ-aṣẹ ti o jẹ koko-ọrọ ti ilokulo ti a fi ẹsun kan; (2) apejuwe ti akoonu ti a fi ẹsun kan ati alaye ti o to lati gba wa laaye lati wa akoonu naa; (3) alaye olubasọrọ fun ọ, pẹlu adirẹsi rẹ, nọmba foonu ati adirẹsi imeeli; (4) alaye nipasẹ rẹ pe o ni igbagbọ rere pe akoonu ni ọna ti o ni ẹsun ti ko ni aṣẹ nipasẹ eni aṣẹ-aṣẹ, tabi aṣoju rẹ, tabi nipasẹ iṣẹ ti ofin eyikeyi;

(5) ìpolongo kan láti ọ̀dọ̀ rẹ, tí o fìdí rẹ̀ múlẹ̀ lábẹ́ ìjìyà ẹ̀rí èké, pé ìsọfúnni tó wà nínú ìkéde náà tọ̀nà àti pé o ní àṣẹ láti mú kí àwọn ẹ̀tọ́ ọmọnìyàn tí wọ́n sọ pé wọ́n ti rú ṣẹ ṣẹ;

ati (6) ibuwọlu ti ara tabi itanna ti ẹni ti o ni aṣẹ tabi eniyan ti o ni aṣẹ lati ṣiṣẹ ni orukọ ẹni ti o ni aṣẹ.

Ti o ko ba ṣafikun gbogbo alaye ti o wa loke le ja si idaduro ti ṣiṣe ẹdun rẹ.

Ìfọ̀rọ̀wérọ̀

Jọwọ fi imeeli ranṣẹ si wa pẹlu eyikeyi ibeere / imọran.

How to treat urticaria?

Urticaria, commonly known as hives, is a skin condition characterized by itchy, raised welts that can appear on any part of the body.

It can be caused by various factors, including allergic reactions, infections, or underlying medical conditions.

Treatment for urticaria depends on the severity of the condition and the underlying cause.

Here are some common treatment options:

1. Antihistamines: These medications help to reduce itching and swelling by blocking the effects of histamine, a chemical released by the body during an allergic reaction.

Over-the-counter antihistamines such as diphenhydramine (Benadryl) or loratadine (Claritin) can be effective in mild cases.

In more severe cases, a doctor may prescribe stronger antihistamines.

2. Corticosteroids: In cases where antihistamines are not effective, corticosteroids such as prednisone may be prescribed to reduce inflammation and suppress the immune system.

These medications are usually taken orally and can provide quick relief.

3. Immunosuppressants: In cases of chronic urticaria that do not respond to other treatments, immunosuppressant drugs such as cyclosporine or methotrexate may be prescribed to suppress the immune system and reduce inflammation.

4. Omalizumab: This medication is an injectable monoclonal antibody that targets and blocks immunoglobulin E (IgE), a protein involved in allergic reactions.

It is typically used for chronic urticaria that does not respond to other treatments.

5. Avoid triggers: Identifying and avoiding triggers that cause urticaria can help prevent outbreaks.

Common triggers include certain foods, medications, insect bites, and exposure to heat, cold, or sunlight.

6. Cold compress: Applying a cold compress to the affected area can help reduce itching and swelling.

7. Wet wraps: Wet wraps can be used to soothe itching and reduce inflammation.

A damp cloth is wrapped around the affected area, and then a dry cloth is placed over it to retain moisture.

8. Phototherapy: Exposure to ultraviolet light can help suppress the immune system and reduce inflammation in some cases of chronic urticaria.

It is important to consult a healthcare professional for proper diagnosis and treatment of urticaria.

They can help determine the underlying cause and recommend the most appropriate treatment plan.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.